Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REBBeCA II: Risedronate for Bone Loss in Breast Cancer
NCT00485953Phase 4Completed
- Start
- Sep 2007
- Primary completion
- Mar 2013
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate in osteoporosis. Started Sep 2007; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00485953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485953.